Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenytoin-induced teratogenesis: a mouse model

R H Finnell

    Science (New York, N.Y.)
    |January 30, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Fetal hydantoin syndrome malformations were replicated in mice. Defects correlated with maternal drug levels, not genetics or seizures, offering insights into teratogenicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    De novo ALX4 variant detected in child with non-syndromic craniosynostosis.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2021
    Same author

    Corrigendum to "Digenic variants of planar cell polarity genes in human neural tube defect patients." Mol Genet Metab. 2018 May;124(1):94-100. doi:10.1016/j.ymgme.2018.03.005. Epub 2018 Mar 18. https://pubmed.ncbi.nlm.nih.gov/29573971/.

    Molecular genetics and metabolism·2021
    Same author

    Papers from the Eighth International Neural Tube Defects Conference.

    Birth defects research. Part A, Clinical and molecular teratology·2014
    Same author

    Screening for reproductive toxicity in Fundulus heteroclitus by genetic expression profiling.

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2013
    Same author

    Association between inhibited binding of folic acid to folate receptor alpha in maternal serum and folate-related birth defects in Norway.

    Human reproduction (Oxford, England)·2011
    Same author

    Importance of gene-environment interactions in the etiology of selected birth defects.

    Clinical genetics·2009
    Same journal

    Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

    Science (New York, N.Y.)·2026
    Same journal

    Local signals, systemic decline.

    Science (New York, N.Y.)·2026
    Same journal

    The mechanics of liver regeneration.

    Science (New York, N.Y.)·2026
    Same journal

    Computing in a memory with physics.

    Science (New York, N.Y.)·2026
    Same journal

    Retraction.

    Science (New York, N.Y.)·2026
    Same journal

    Making time.

    Science (New York, N.Y.)·2026
    See all related articles

    Area of Science:

    • Teratology
    • Developmental Biology
    • Pharmacology

    Background:

    • Fetal hydantoin syndrome (FHS) is a set of birth defects linked to prenatal exposure to hydantoin anticonvulsant drugs.
    • The exact mechanisms and contributing factors to FHS remain incompletely understood.

    Purpose of the Study:

    • To establish and characterize a mouse model for Fetal Hydantoin Syndrome.
    • To investigate the correlation between maternal drug exposure levels and the occurrence of specific malformations.

    Main Methods:

    • Administration of hydantoin anticonvulsants to pregnant mice.
    • Monitoring of maternal serum drug concentrations.
    • Detailed examination of fetal development for malformations.

    Main Results:

    Related Experiment Videos

    • The mouse model successfully reproduced malformations characteristic of Fetal Hydantoin Syndrome.
    • A significant correlation was observed between maternal serum concentrations of the drug and the incidence of fetal defects.
    • No correlation was found between the occurrence of defects and the maternal or fetal genotype, or the presence of a seizure disorder in the mother.

    Conclusions:

    • Maternal serum drug concentration is a critical factor in the development of Fetal Hydantoin Syndrome.
    • Genetic background and maternal seizure disorder do not appear to be primary drivers of these specific drug-induced malformations in this model.